Skip to main content
Premium Trial:

Request an Annual Quote

Genospectra Licenses Affymetrix Bead Technology for RNA Quantification

NEW YORK, Nov. 11 (GenomeWeb News) - Genospectra has taken a non-exclusive license to Affymetrix patents related to bead technology and gene-expression analysis, the two companies said yesterday afternoon.


Genospectra will use the technology with its signal-amplification techniques to develop methods to quantify RNA directly from cell lysates or tissue homogenates.

 

Financial details were not disclosed.

 

In April, Affymetrix said it would begin offering "reasonable terms" and would license or sell in "selected areas" some of its most recently issued patents, as well as some early patents relating to bead-based molecular technologies.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.